Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 15/20 | 1.00 |
| ▸ | ITGA2B | P08514 | 15/20 | 1.00 |
| ▸ | F2 | P00734 | 5/20 | 0.63 |
| ▸ | F10 | P00742 | 4/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6471417 | 0.91 | ITGB3 (0.83) | ITGB3ITGA2BF2F10 | |
| SCHEMBL6473800 | 0.91 | ITGB3 (0.83) | ITGB3ITGA2BF2F10 | |
| SCHEMBL6475730 | 0.88 | ITGB3 (1.00) | ITGB3ITGA2BF2F10 | |
| Acetic Acid SCHEMBL6474255 | 0.87 | ITGB3 (1.00) | ITGB3ITGA2BF2F10 | |
| SCHEMBL6474923 | 0.87 | ITGB3 (0.76) | ITGB3ITGA2BF2F10 | |
| SCHEMBL6473921 | 0.87 | ITGB3 (0.76) | ITGB3ITGA2BF2F10 | |
| SCHEMBL6471849 | 0.85 | ITGB3 (1.00) | ITGB3ITGA2BF2F10 | |
| Acetic Acid SCHEMBL6474725 | 0.84 | ITGB3 (1.00) | ITGB3ITGA2BF2F10 | |
| SCHEMBL6474734 | 0.83 | ITGB3 (0.85) | ITGB3ITGA2BF2F10 | |
| SCHEMBL6532497 | 0.82 | ITGB3 (0.70) | ITGB3ITGA2BF2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200392107-A1 | CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF | TORAY INDUSTRIES, INC. (JP) | 2020-12-17 | — | — | US | disclosed |
| EP-3747879-A1 | CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | Toray Industries, Inc. (JP) | 2020-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200392107-A1 | CYCLIC AMINE DERIVATIVE AND MEDICAL USE THEREOF | NPR3, SLC10A1, CNR2 | ITGB3 1790/4885ITGA2B 3561/4885F2 2266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.